Near-4,000% surge catapults one tiny biotech firm to record week
An under-the-radar biotech firm called Tempest Therapeutics Inc. notched its best week on record after results from a liver cancer trial sent the stock surging 3,973% — and tumbling the next day. Wall Street cheered as the stock shot up to $9.77 on Wednesday when the drug developer said its experimental cancer therapy in a … Read more